Local view for "http://purl.org/linkedpolitics/eu/plenary/2012-07-03-Speech-2-447-000"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2012-07-03"^^xsd:date2
dcterms:Is Part Of	lp_eu:Anti-Counterfeiting Trade Agreement between the EU and its Member States, Australia, Canada, Japan, the Republic of Korea, Mexico, Morocco, New Zealand, Singapore, Switzerland and the USA (debate)2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20120703.21.2-447-000"2
lpv:hasSubsequent	lp_eu:2012-07-03-Speech-2-448-0002
lpv:speaker	lp:Marielle Boullier Gallo2
lpv:spokenAs	substitute; EMPL (2012-01-19--2014-06-30)3 member; CRIM (2012-03-28--2013-10-23)3 member_of_the_bureau; EPP (2009-09-16--2014-06-30)3 substitute; IMCO (2012-01-19--2014-06-30)3 member; Delegation for relations with the United States (2009-09-16--2014-06-30)3 unknown; La Gauche moderne (2009-07-14--2013-02-03)3 substitute; Delegation for relations with India (2009-09-16--2014-06-30)3 member; JURI (2012-01-19--2014-06-30)3
lpv:translated text	"I hope I have misunderstood. I hope I have misunderstood that you are telling me that counterfeit medicines save lives. Generic medicines are another matter. I heard ‘counterfeit’. There is a big difference, after all! With regard to generic medicines, there is no problem with ACTA. You know this very well. Therefore, I do not understand the relevance of this question."@en1
lpv:unclassifiedMetadata	"(The speaker agreed to take a blue-card question under Rule 149(8))"1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph